PATH
183
9
13
145
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 25/100
7.7%
14 terminated/withdrawn out of 183 trials
91.2%
+4.6% vs industry average
22%
41 trials in Phase 3/4
55%
80 of 145 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (183)
Infant Malaria Vaccine Schedule Optimization
Role: lead
Study of a Novel Type 1 Oral Poliomyelitis Vaccine in Bangladesh
Role: lead
Ethiopian Antimalarial Therapeutic Efficacy Study 2026
Role: collaborator
Short Course Primaquine for the Radical Cure of P. Vivax - Papua New Guinea
Role: collaborator
FocaL Mass Drug Administration for Vivax Malaria Elimination
Role: collaborator
Study of a Novel Type 3 Oral Poliomyelitis Vaccine in Panama
Role: lead
Dose-Ranging Study to Evaluate a 25-Valent Pneumococcal Conjugate Vaccine
Role: collaborator
Impact of a Cricket and Black Soldier Fly Larvae-Fortified Cracker on the Gut Microbiome and Iron Status in Malagasy Schoolchildren
Role: collaborator
Low Birthweight and Preterm Infant Feeding Trial and Supportive Care Package: Implementation Research
Role: collaborator
LIFT-UP: Randomized Controlled Trial of Fortification of Human Milk
Role: collaborator
Short Course Primaquine for the Radical Cure of P. Vivax Malaria - Indonesia
Role: collaborator
Study of Co-administered (Types 1 & 2) Novel Oral Poliomyelitis Vaccines Evaluation
Role: lead
Phase I/II Study to a Assess the GBS-06 Vaccine Manufactured by Inventprise, Inc., in Healthy, Non-Pregnant, Adult Women of Childbearing Age.
Role: collaborator
Assessing the Acceptability, Feasibility, Effectiveness and Cost-effectiveness of LADB
Role: lead
Low Dead-space Injecting Equipment Distribution Program for People Who Inject Drugs in Low- and Middle-income Countries
Role: collaborator
Developing a Screening Tool for Primary Immunodeficiency Disease (PID) in Pakistan
Role: lead
Evaluation of an IgG Deficiency Rapid Screening Test: A Performance Study With Primary Immunodeficiency (PID) Patients in Tunisia
Role: lead
Study of Trivalent and Bivalent (Types 1 & 2) Novel Oral Poliomyelitis Vaccines
Role: lead
Clinical Study of Meningococcal ACYWX Conjugate Vaccine, in 12-16 Month Olds
Role: collaborator
Human Challenge With Live-attenuated Rotavirus to Assess Next-generation Rotavirus Vaccines in Africa
Role: collaborator